You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Express Scripts
Johnson and Johnson

Last Updated: February 24, 2020

DrugPatentWatch Database Preview

Litigation Details for MERCK, SHARP & DOHME CORP. v. HETERO USA INC. (D.N.J. 2015)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

MERCK, SHARP & DOHME CORP. v. HETERO USA INC. (D.N.J. 2015)

Docket   Start Trial Date Filed 2015-11-16
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Michael Andre Shipp
Jury Demand None Referred To Lois H. Goodman
Parties BRISTOL-MYERS SQUIBB COMPANY; BRISTOL-MYERS SQUIBB PHARMA CO.; HETERO LABS LIMITED UNIT-III; HETERO USA INC.; MERCK, SHARP & DOHME CORP.
Patents 6,639,071; 6,939,964
Attorneys GREGORY J. BEVELOCK
Firms Law Office of Gregory J. Bevelock, LLC
Link to Docket External link to docket
Small Molecule Drugs cited in MERCK, SHARP & DOHME CORP. v. HETERO USA INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for MERCK, SHARP & DOHME CORP. v. HETERO USA INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-11-16 1 . 19. United States Patent No. 6,639,071 (“the ‘071 Patent”), entitled “Crystal Forms of … Declaratory Judgment of Patent Infringement of U.S. Patent No. 6,639,071 38. Plaintiffs… Infringement of U.S. Patent No. 6,639,071 30. Plaintiffs repeat and re-allege…infringed one or more claims of United States Patent No. 6,639,071 by the filing of ANDA No. 078886; …than the expiration date of United States Patent No. 6,639,071 or any later date of exclusivity to which External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Harvard Business School
Johnson and Johnson
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.